MorphoSys and Novartis Sign Antibody Agreement
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 49 (Table of Contents)
Published: 4 Jul-2004
DOI: 10.3833/pdr.v2004.i49.797 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
MorphoSys formed a 3-year strategic alliance with Novartis to discover and develop antibody-based therapeutics for a variety of diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
RSS